Generalized anxiety disorder
The reported estimated prevalence of GAD is 0.9% among adolescents and 2.9% among adults. Approximately one-third of the risk for developing GAD is attributable to genetic predisposition. It is common to have first-degree relatives with a number of anxiety and mood disorders. GAD is more commonly diagnosed among women than men. Patients often begin experiencing increasing worry in their youth and develop more severe and persistent symptoms later in life, often in their 20s and 30s.
GAD is distinguished from other anxiety disorders by longstanding, general worry that spans across multiple aspects of life and the lack of a specific trigger or focused, singular concern. People with GAD may also present with neuroticism and harm-avoidance behaviors. Individuals may exhibit features of obsessive-compulsive disorder (OCD) like counting, checking, and intrusive thoughts. But unlike OCD, these features in GAD are not time consuming or ritualized, and they tend to revolve around avoiding adverse outcomes in day-to-day activities rather than focusing on intrinsic fears.
GAD may co-occur with other disorders such as major depression, panic disorder, social phobia, and specific phobias. Patients with this disorder may have an increased risk of various general medical conditions.
Related topic: Drug-induced anxiety
F41.1 – Generalized anxiety disorder
21897009 – Generalized anxiety disorder
- Drug-induced anxiety
- Other anxiety disorders – social anxiety disorder, specific phobia, panic disorder, agoraphobia
- Obsessive-compulsive disorder
- Posttraumatic stress disorder
- Adjustment disorders
- Depressive disorders
- Bipolar disorders
- Psychotic disorders – schizophrenia, schizoaffective disorder, brief psychotic disorder
- Cluster C personality disorders – avoidant, dependent, obsessive-compulsive
- Paranoid personality disorder, a cluster A disorder
- Anxiety secondary to a medical disorder – pheochromocytoma, hyperthyroidism, irritable bowel syndrome, or acute coronary syndrome